Who is sponsoring NCT05078320?

NCT05078320 is sponsored by Karolinska Institutet.

What drugs are being tested in NCT05078320?

Interventions in NCT05078320: Exposure and response prevention (ERP).

What condition does NCT05078320 study?

NCT05078320 studies Body Dysmorphic Disorders, Dysmorphophobia.

Is NCT05078320 still recruiting?

NCT05078320 is currently completed. Last updated 4 October 2023.

Last reviewed 2023-10-04 · How we verify

NCT05078320

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Internet-delivered Cognitive-behaviour Therapy for Adolescents With Body Dysmorphic Disorder

Completed NA Last updated 4 October 2023

What this trial tests

NA trial testing Exposure and response prevention (ERP) in Body Dysmorphic Disorders in 20 participants. Completed in 26 June 2023.

Timeline

22 October 2021

Primary endpoint
6 September 2022

26 June 2023

Quick facts

Lead sponsor	Karolinska Institutet
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	22 October 2021
Primary completion	6 September 2022
Estimated completion	26 June 2023
Sites	1 location across Sweden

Drugs / interventions tested

Exposure and response prevention (ERP)

Conditions studied

Body Dysmorphic Disorders — all drugs for Body Dysmorphic Disorders →
Dysmorphophobia — all drugs for Dysmorphophobia →

Sponsor

Karolinska Institutet

Who can join

Adults 12 to 17, any sex, with Body Dysmorphic Disorders or Dysmorphophobia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this trial is to investigate whether a therapist-guided Internet-delivered cognitive behaviour therapy (ICBT) programme is feasible for adolescents with body dysmorphic disorder (BDD). The aim is to evaluate feasibility and provide preliminary efficacy data.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Therapist-guided, Internet-delivered cognitive behaviour therapy for adolescents with body dysmorphic disorder: A feasibility trial with long-term follow-up.
Rautio D, Andrén P, Gumpert M, Jolstedt M, et al · · 2023 · cited 7× · PMID 38034863 · DOI 10.1016/j.invent.2023.100688

Verify or expand the search:

Other trials of Exposure and response prevention (ERP)

Trials testing the same drug.

NCT05064527 — A Wearable AI Feedback Tool for Pediatric OCD · completed
NCT03916055 — Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder · NA · completed

Other recruiting trials for Body Dysmorphic Disorders

Currently open trials in the same condition.

NCT06262412 — Internet-delivered Cognitive-behaviour Therapy for Child and Adolescent Body Dysmorphic Disorder · NA · recruiting
NCT03918577 — Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders · NA · recruiting
NCT04899687 — Study of Dextromethorphan in OCD and Related Disorders · Phase 2 · recruiting

Other Karolinska Institutet trials

Trials by the same sponsor.

NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05078320 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
Last refreshed: 4 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05078320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing